Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins - PubMed (original) (raw)
Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins
A B Hittelman et al. EMBO J. 1999.
Abstract
The hormone-activated glucocorticoid receptor (GR), through its N- and C-terminal transcriptional activation functions AF-1 and AF-2, controls the transcription of target genes presumably through interaction(s) with transcriptional regulatory factors. Utilizing a modified yeast two-hybrid approach, we have identified the tumor susceptibility gene 101 (TSG101) and the vitamin D receptor-interacting protein 150 (DRIP150) as proteins that interact specifically with a functional GR AF-1 surface. In yeast and mammalian cells, TSG101 represses whereas DRIP150 enhances GR AF-1-mediated transactivation. Thus, GR AF-1 is capable of recruiting both positive and negative regulatory factors that differentially regulate GR transcriptional enhancement. In addition, we show that another member of the DRIP complex, DRIP205, interacts with the GR ligand binding domain in a hormone-dependent manner and facilitates GR transactivation in concert with DRIP150. These results suggest that DRIP150 and DRIP205 functionally link GR AF-1 and AF-2, and represent important mediators of GR transcriptional enhancement.
Similar articles
- CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI, Cidlowski JA. McKay LI, et al. Mol Endocrinol. 2000 Aug;14(8):1222-34. doi: 10.1210/mend.14.8.0506. Mol Endocrinol. 2000. PMID: 10935546 - AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
Boruk M, Savory JG, Haché RJ. Boruk M, et al. Mol Endocrinol. 1998 Nov;12(11):1749-63. doi: 10.1210/mend.12.11.0191. Mol Endocrinol. 1998. PMID: 9817600 - Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain.
Wallberg AE, Flinn EM, Gustafsson JA, Wright AP. Wallberg AE, et al. Biochem Soc Trans. 2000;28(4):410-4. Biochem Soc Trans. 2000. PMID: 10961930 Review.
Cited by
- Nuclear receptors and their selective pharmacologic modulators.
Burris TP, Solt LA, Wang Y, Crumbley C, Banerjee S, Griffett K, Lundasen T, Hughes T, Kojetin DJ. Burris TP, et al. Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23457206 Free PMC article. Review. - The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.
Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. Reily MM, et al. EMBO J. 2006 Jan 11;25(1):108-17. doi: 10.1038/sj.emboj.7600919. Epub 2005 Dec 15. EMBO J. 2006. PMID: 16362036 Free PMC article. - Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells.
Carstens MJ, Krempler A, Triplett AA, Van Lohuizen M, Wagner KU. Carstens MJ, et al. J Biol Chem. 2004 Aug 20;279(34):35984-94. doi: 10.1074/jbc.M400408200. Epub 2004 Jun 21. J Biol Chem. 2004. PMID: 15210712 Free PMC article. - TBP binding-induced folding of the glucocorticoid receptor AF1 domain facilitates its interaction with steroid receptor coactivator-1.
Khan SH, Ling J, Kumar R. Khan SH, et al. PLoS One. 2011;6(7):e21939. doi: 10.1371/journal.pone.0021939. Epub 2011 Jul 7. PLoS One. 2011. PMID: 21760925 Free PMC article. - MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
Liu G, Sprenger C, Wu PJ, Sun S, Uo T, Haugk K, Epilepsia KS, Plymate S. Liu G, et al. Oncotarget. 2015 Jan 1;6(1):288-304. doi: 10.18632/oncotarget.2672. Oncotarget. 2015. PMID: 25481872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources